Laurent Chardonnet, Chief Financial Officer at Prelude Therapeutics Inc (PRLD), bought 5,000 shares at $5.50 ($28K) on 2023-05-23, disclosed to the SEC on 2023-05-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| AXLA | BUY | 2020-01-31 | $15K | — | Filing → |
| AXLA | BUY | 2020-01-28 | $3K | — | Filing → |
| INCY | SELL | 2015-04-01 | $10.7M | — | Filing → |